http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107468683-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate | 2017-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107468683-B |
| titleOfInvention | Application of alantolactone and derivatives thereof in preparation of medicines for preventing and treating fatty liver injury |
| abstract | The invention discloses an application of alantolactone and derivatives thereof in preparing a medicament for preventing and treating fatty liver injury, which can relieve the lipid metabolism disorder condition of liver cells and inhibit TG and TC levels in the liver cells induced by oxLDL and the accumulation condition of intracellular lipid droplets; can prevent and treat liver injury caused by alcoholic fatty liver, and effectively improve liver function and dyslipidemia; can prevent and treat liver injury caused by non-alcoholic fatty liver, effectively improve liver function and dyslipidemia, has the characteristics of small toxic and side effects and good curative effect compared with the prior various lipid-lowering medicines, and has the potential of developing natural low-toxicity lipid-lowering medicines with clinical application value. |
| priorityDate | 2017-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.